|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquired
|
gptkb:Blue_Rock_Therapeutics
gptkb:Medi_Gene_AG
gptkb:Onyx_Pharmaceuticals
gptkb:Schering_AG
gptkb:Conceptus,_Inc.
|
|
gptkbp:collaborates_with
|
Healthcare professionals
|
|
gptkbp:employs
|
Thousands of employees
|
|
gptkbp:engages_in
|
gptkb:Research_Institute
|
|
gptkbp:focuses_on
|
Prescription medications
|
|
gptkbp:founded
|
1863
|
|
gptkbp:has_part
|
Crop Science Division
Consumer Health Division
Animal Health Division
|
|
gptkbp:has_product
|
gptkb:Xarelto
gptkb:Avelox
gptkb:Eylea
gptkb:Adempas
gptkb:Kovaltry
gptkb:Nexavar
gptkb:Stivarga
gptkb:drug
Finacea
|
|
gptkbp:has_social_media
|
gptkb:Linked_In
gptkb:Twitter_account
|
|
gptkbp:has_website
|
www.bayer.com
|
|
gptkbp:headcount
|
gptkb:CEO_of_Bayer_AG
|
|
gptkbp:headquartered_in
|
gptkb:Leverkusen,_Germany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bayer's Pharmaceuticals Division
|
|
gptkbp:is_involved_in
|
Health education
Clinical trials
Public health initiatives
Patient support programs
|
|
gptkbp:is_known_for
|
gptkb:Sustainability_initiatives
High-quality products
Innovative therapies
|
|
gptkbp:operates_in
|
Global Market
|
|
gptkbp:part_of
|
gptkb:Bayer_AG
|
|
gptkbp:regulates
|
gptkb:FDA
gptkb:EMA
Other health authorities
|
|
gptkbp:research_areas
|
Bayer Research Center
|
|
gptkbp:revenue
|
Billions of euros
|
|
gptkbp:targets
|
gptkb:healthcare_organization
gptkb:Cardiovascular_diseases
gptkb:sneaker
Women's health
Chronic diseases
|
|
gptkbp:bfsParent
|
gptkb:Blue_Rock_Therapeutics
|
|
gptkbp:bfsLayer
|
3
|